Talk:NNC 63-0532
This article is rated Stub-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||
|
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about NNC 63-0532.
|
US7081463B2 Hydroxy alkyl substituted 1,3,8-Triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1receptor mediated disorders
Above I provide the original patent. I did not add it to the page as I added 857 CORRECT patents to medicines ovcer 3 years and over 500 of them were removed. I used Reaxys & Drugfuture to confirm that the patents were cvorrecvt and yet they were removed. The best example is that I added patents to every sing barbiturate and they have ALL gone. I would like to know why as patents are of great utility to those in postgraduate studies in medicinal chemistry. I was reduced to releasing the Eunoia disc with EVERY patent on it and I know 1000s of copies are in circulation.
Start a discussion about improving the NNC 63-0532 page
Talk pages are where people discuss how to make content on Wikipedia the best that it can be. You can use this page to start a discussion with others about how to improve the "NNC 63-0532" page.